News
Marburg is one scary disease. The fatality rate can be as high as 88%. There's no approved vaccine — yet. With one of the world's largest outbreaks, Rwanda is now testing a promising new vaccine.
Public Health Vaccines, which is developing a Marburg vaccine using the same vaccine platform as Merck’s licensed Ebola Zaire vaccine, has roughly 300 doses that could be used in a field trial ...
There are no treatments or vaccines for Marburg, but there are some candidates that have shown promise in Phase 1 clinical trials. However these candidates must be tested in active outbreaks to ...
Marburg virus is hard to detect early on--and goes on to kill about half its victims. Researchers hope to work quickly during this outbreak to make progress on emerging vaccines and treatments.
Hosted on MSN9mon
Marburg vaccines rushed to Rwanda to protect healthcare workers battling outbreak - MSNMarburg vaccines are set to arrive in Rwanda in the coming days to help protect healthcare workers fighting an outbreak of the deadly haemorrhagic fever. The jabs, developed by the Sabin Vaccine ...
Marburg vaccine shows promising results in first-in-human study. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2023 / 01 / 230130130531.htm.
Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S ...
Oxford University, which is developing another Marburg vaccine, had about 1,000 doses. Larger-scale production could be needed, especially if the outbreak becomes more widespread.
No vaccine or antiviral treatment is approved to treat Marburg virus disease, which has an average death rate of around 50%, according to the WHO. On Tuesday, the WHO convened an urgent meeting to ...
The nonprofit vaccine developer has now sent about 1,700 shots to Rwanda, where Marburg cases have been mostly concentrated among health workers who got the virus while treating sick patients. How ...
KIGALI, Rwanda (AP) — Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said Sunday, as the East African country tries to stop the spread of ...
Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever as the East African country tries to stop the spread of an outbreak that has killed 12 people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results